Benign metastasizing leiomyoma responsive to megestrol: Case report and review of the literature

International Journal of Gynecological Cancer

Volumn 15, Issue 6, 2005, Pages 1213-1217

  Wentling, G K ^a   Sevin, Bernd Uwe ^a   Geiger, X J ^a   Bridges, M D ^a  

^a MAYO CLINIC   (United States)

Author keywords

Benign metastasizing leiomyoma; Lung neoplasm; Megestrol; Progesterone

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; MEGESTROL; PROGESTERONE; PROGESTERONE RECEPTOR;

ABDOMINAL HYSTERECTOMY; ADULT; ANAMNESIS; BENIGN TUMOR; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG RESPONSE; FEMALE; GYNECOLOGIC SURGERY; HISTOLOGY; HORMONAL THERAPY; HUMAN; LUNG PARENCHYMA; LUNG RESECTION; OVARY CYST; PRIORITY JOURNAL; REVIEW; SALPINGOOOPHORECTOMY; UTERUS MYOMA;

ADULT; ANTINEOPLASTIC AGENTS, HORMONAL; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; LEIOMYOMA; LUNG NEOPLASMS; MEGESTROL; NEOPLASM METASTASIS; PELVIC NEOPLASMS; PNEUMONECTOMY; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; TREATMENT OUTCOME; UTERINE NEOPLASMS;

EID: 30944442052     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2005.00190.x     Document Type: Review

References (23)

1. Steiner PE. Metastasizing fibroleiomyoma of the uterus: report of a case and review of the literature. Am J Pathol 1939;15:89-110.
2. Sabatini R, Ferreri R, Distante G, Loizzi V, Loizzi P. Benign metastasizing leiomyoma in the lung: a case report. Eur J Gynaecol Oncol 2002;23:445-6.
3. Kayser K, Zink S, Schneider T et al. Benign metastasizing leiomyoma of the uterus: documentation of clinical, immunohistochemical and lectin-histochemical data of ten cases. Virchows Arch 2000;437: 284-92.
4. Wolff M, Silva F, Kaye G. Pulmonary metastases (with admixed epithelial elements) from smooth muscle neoplasms: report of nine cases, including three males. Am J Surg Pathol 1979;3:325-42.
5. Jautzke G, Müller-Ruchholtz E, Thalmann U. Immunohistological detection of estrogen and progesterone receptors in multiple and well differentiated leiomyomatous lung tumors in women with uterine leiomyomas (so-called benign metastasizing leiomyomas): a report on 5 cases. Pathol Res Pract 1996;192:215-23.
6. Weiss SW, Goldblum JR. Enzinger and Weiss's soft tissue tumors, 4th edn. St. Louis, MO: Mosby 2001:727-48.
7. Tedeschi LG. Multiple pulmonary fibroleiomyomas. Am J Obstet Gynecol 1980;138:468-70.
8. Abu-Rustum NR, Curtin JP, Burt M, Jones WB. Regression of uterine low-grade smooth-muscle tumors metastatic to the lung after oophorectomy. Obstet Gynecol 1997;89:850-2.
9. Horstmann JP, Pietra GG, Harman JA, Cole NG, Grinspan S. Spontaneous regression of pulmonary leiomyomas during pregnancy. Cancer 1977;39:314-21.
10. Arai T, Yasuda Y, Takaya T, Shibayama M. Natural decrease of benign metastasizing leiomyoma [communications to the editor], Chest 2000;117:921-2.
11. Banner AS, Carrington CB, Emory WB et al. Efficacy of oophorectomy in lymphangioleiomyomatosis and benign metastasizing leiomyoma. N Engl J Med 1981;305:204-9.
12. Hague WM, Abdulwahid NA, Jacobs HS, Craft I. Use of LHRH analogue to obtain reversible castration in a patient with benign metastasizing leiomyoma. Br J Obstet Gynaecol 1986;93:455-60.
13. Jacobson TZ, Rainey EJ, Turton CWG. Pulmonary benign metastasising leiomyoma: response to treatment with goserelin. Thorax 1995;50:1225-6.
14. Cohen JD, Robins HI. Response of "benign" metastasizing leiomyoma to progestin withdrawal: case report. Eur J Gynaecol Oncol 1993;14: 44-5.
15. Cramer SF, Meyer JS, Kraner JF, Camel M, Mazur MT, Tenenbaum MS. Metastasizing leiomyoma of the uterus: S-phase fraction, estrogen receptor, and ultrastructure. Cancer 1980;45:932-7.
16. Dai D, Kumar NS, Wolf DM, Leslie KK. Molecular tools to reestablish progestin control of endometrial cancer cell proliferation. Am J Obstet Gynecol 2001;184:790-7.
17. Bodner K, Bodner-Adler B, Kimberger O, Czerwenka K, Leodolter S, Mayerhofer K. Estrogen and progesterone receptor expression in patients with uterine leiomyosarcoma and correlation with different clinicopathological parameters. Anticancer Res 2003;23:729-32.
18. Zhai Y.-L, Kobayashi Y, Mori A et al. Expression of steroid receptors, Ki-67, and p53 in uterine leiomyosarcomas. Int J Gynecol Pathol 1999;18:20-8.
19. Wade K, Quinn MA, Hammond I, Williams K, Cauchi M. Uterine sarcoma: steroid receptors and response to hormonal therapy. Gynecol Oncol 1990;39:364-7.
20. Sutton GP, Stehman FB, Michael H, Young PCM, Ehrlich CE. Estrogen and progesterone receptors in uterine sarcomas. Obstet Gynecol 1986;68:709-14.
21. Soper JT, McCarty KS Jr, Hinshaw W, Creasman WT, McCarty KS Sr, Clarke-Pearson DL. Cytoplasmic estrogen and progesterone receptor content of uterine sarcomas. Am J Obstet Gynecol 1984;150: 342-8.
22. Rein MS. Advances in uterine leiomyoma research: the progesterone hypothesis. Environ Health Perspect 2000;108(Suppl. 5): 791-3.
23. Andersen J. Growth factors and cytokines in uterine leiomyomas. Semin Reprod Endocrinol 1996;14:269-82.